Sebastien Deville

Sebastien Deville has a diverse work experience spanning multiple companies and roles. Sebastien worked at SEPPIC from 2005 to 2011, primarily focusing on Scientific Marketing. During this time, they were involved in R&D collaboration, project proposal management, creating marketing tools, and attending international conferences.

In 2011, Sebastien joined Airliquide India as the South Asia Business Development Manager for the A.V.I. Business unit. Their responsibilities included sales management, reporting to Asia area management, and managing the distribution network.

Sebastien returned to SEPPIC in 2014 and took on the role of Area Business Development Manager for the Pharmacy BU. Sebastien was responsible for key account management, sales management, and reporting to the Pharmacy BU management. Sebastien also managed the distribution network and handled customer project management.

In 2016, Sebastien transitioned to the role of ASIA Vaccine Adjuvant & Injectable Business Manager at SEPPIC. Sebastien held this position until 2020, overseeing sales and business development in the Asian market.

From 2020 to 2022, Sebastien served as the Europe Business Development & Open Innovation Manager in the Vaccine Adjuvant Market at SEPPIC.

Lastly, Sebastien assumed the position of Sales Manager - Pharmaceutical, Nutrition & AVI markets - Western Europe at SEPPIC in 2022. In this role, they lead a team responsible for managing the sales of excipients and active ingredients in the Pharmacy, Nutrition, and Animal Health markets in Western Europe and North Africa.

Sebastien Deville attended the Conservatoire National des Arts et Métiers from 2000 to 2007. During this time, they pursued a degree in Engineering with a specialization in "Sciences et Techniques du Vivant" (Life Sciences) and an option in "Génie Biologique" (Biological Engineering).